Study of COYA 302 for the Treatment of ALS

Barrow Neurological Institute, Phoenix, Arizona, United States

Cedars-Sinai Medical Center, Los Angeles, California, United States

California Pacific Medical Center, San Francisco, California, United States

Nova Southeastern University, Davie, Florida, United States

University of Florida Clinical and Translational Research Center, Gainesville, Florida, United States

University Of Miami, Miami, Florida, United States

University of South Florida, Tampa, Florida, United States

Emory University, Atlanta, Georgia, United States

Northwestern, Chicago, Illinois, United States

Johns Hopkins, Baltimore, Maryland, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

University of Michigan, Ann Arbor, Michigan, United States

Washington University, St Louis, Missouri, United States

Neurology Associates, P.C. Somnos Clinical Research, Lincoln, Nebraska, United States

Columbia University Medical Center ALS Center, New York, New York, United States

Thomas Jefferson University-Weinberg ALS Center, Philadelphia, Pennsylvania, United States

Temple Neurology, Philadelphia, Pennsylvania, United States

Austin Neuromuscular Center; National Neuromuscular Research Institute, PLLC, Austin, Texas, United States

Texas Neurology, PA, Dallas, Texas, United States

Houston Methodist Stanley H. Appel Department of Neurology, Houston, Texas, United States

The University of Texas Health Science Center, San Antonio, Texas, United States

University of British Columbia, Vancouver, British Columbia, Canada

London Health Sciences Center, London, Ontario, Canada

University of Toronto/Sunnybrook Health Sciences Center, Toronto, Ontario, Canada

Hopital Neurologique de Montreal, Montreal, Quebec, Canada